Clinical Outcome with Allogeneic Hematopoietic Stem Cell Transplantation after Blinatumomab or Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia: Real World Experience

被引：0

作者：

Badar, Talha ^{[1
]}

Advani, Anjali S. ^{[2
]}

Liedtke, Michaela ^{[3
]}

Arslan, Shukaib ^{[4
]}

Khan, Muhammad Ali ^{[5
]}

Aldoss, Ibrahim ^{[6
]}

Sienbenaller, Caitlin ^{[7
]}

Schultz, Elizabeth ^{[8
]}

Hefazi, Mehrdad ^{[9
]}

Shallis, Rory Michael ^{[10
]}

Yurkiewicz, Ilana ^{[3
]}

Podoltsev, Nikolai ^{[11
]}

Patel, Anand ^{[12
]}

Curran, Emily ^{[12
]}

Kuo, Eric ^{[3
]}

Wang, Amy ^{[12
]}

Balasubramanian, Suresh ^{[13
]}

Yang, Jay ^{[13
]}

Mattison, Ryan ^{[14
]}

Burkart, Madelyn ^{[15
]}

Dinner, Shira ^{[15
]}

Litzow, Mark R. ^{[16
]}

Wadleigh, Martha ^{[8
]}

Atallah, Ehab ^{[17
]}

机构：

[1] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA

[2] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA

[3] Stanford Univ, Canc Ctr, Stanford, CA 94305 USA

[4] City Hopes, Hematol & Oncol, Duarte, CA USA

[5] Med Coll Wisconsin, Med, Milwaukee, WI 53226 USA

[6] Natl Med Ctr, Hematol Hematopoiet Cell Transplant, City Hope, Duarte, CA USA

[7] Cleveland Clin, Cleveland, OH 44106 USA

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

[9] Mayo Clin, T Cell Engn, Rochester, MN USA

[10] Yale Canc Ctr, Dept Internal Med, Sect Hematol, New Haven, CT USA

[11] Yale Univ, Sch Med, New Haven, CT USA

[12] Univ Chicago, Chicago, IL 60637 USA

[13] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[14] Univ Wisconsin, Hematol Oncol, Madison, WI USA

[15] Northwestern Univ, Chicago, IL 60611 USA

[16] Mayo Clin, Div Hematol, Rochester, MN USA

[17] Med Coll Wisconsin, Hematol & Oncol, Milwaukee, WI 53226 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

136

引用

页码：S101 / S102

页数：2

共 50 条

[1] Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data
Talha Badar
Aniko Szabo
Mark Litzow
Madelyn Burkart
Ilana Yurkiewicz
Shira Dinner
Mehrdad Hefazi
Rory M. Shallis
Nikolai Podoltsev
Anand A. Patel
Emily Curran
Martha Wadleigh
Suresh Balasubramanian
Jay Yang
Shukaib Arslan
Ibrahim Aldoss
Ryan Mattison
Danielle Cenin
Caitlin Siebenaller
Anjali Advani
Michaela Liedtke
Ehab Atallah
Bone Marrow Transplantation, 2021, 56 : 1998 - 2004
[2] Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data
Badar, Talha
Szabo, Aniko
Litzow, Mark
Burkart, Madelyn
Yurkiewicz, Ilana
Dinner, Shira
Hefazi, Mehrdad
Shallis, Rory M.
Podoltsev, Nikolai
Patel, Anand A.
Curran, Emily
Wadleigh, Martha
Balasubramanian, Suresh
Yang, Jay
Arslan, Shukaib
Aldoss, Ibrahim
Mattison, Ryan
Cenin, Danielle
Siebenaller, Caitlin
Advani, Anjali
Liedtke, Michaela
Atallah, Ehab
BONE MARROW TRANSPLANTATION, 2021, 56 (08) : 1998 - 2004
[3] Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia
de Lima, Marcos
Kebriaei, Partow
Lanza, Francesco
Cho, Christina
Popradi, Gizelle
Kaur, Manmeet
Zhang, Mei-Jie
Zhang, Fan
Shah, Richa
Vandendries, Erik
Asomaning, Kofi
Dorman, Stephanie
Stelljes, Matthias
Marks, David I.
Saber, Wael
AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (05) : 909 - 912
[4] Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Stein, Anthony S.
Kantarjian, Hagop
Goekbuget, Nicola
Bargou, Ralf
Litzow, Mark R.
Rambaldi, Alessandro
Ribera, Josep-Maria
Zhang, Alicia
Zimmerman, Zachary
Zugmaier, Gerhard
Topp, Max S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1498 - 1504
[5] A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation
Izumi, Akihiko
Tachibana, Takayoshi
Ando, Taiki
Tanaka, Masatsugu
Kanamori, Heiwa
Nakajima, Hideaki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 69 - 76
[6] Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic Leukemia
Borah, Pronamee
Mohan, Vivek
Jain, Sachin
Capoor, Varun
Naithani, Rahul
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
[7] A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation
Akihiko Izumi
Takayoshi Tachibana
Taiki Ando
Masatsugu Tanaka
Heiwa Kanamori
Hideaki Nakajima
International Journal of Hematology, 2022, 115 : 69 - 76
[8] Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study
Seung-Hwan Lee
Jae-Ho Yoon
Gi June Min
Sung-Soo Park
Silvia Park
Sung-Eun Lee
Byung-Sik Cho
Ki-Seong Eom
Yoo-Jin Kim
Hee-Je Kim
Chang-Ki Min
Seok-Goo Cho
Jong Wook Lee
Seok Lee
International Journal of Hematology, 2022, 115 : 135 - 139
[9] Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study
Lee, Seung-Hwan
Yoon, Jae-Ho
Min, Gi June
Park, Sung-Soo
Park, Silvia
Lee, Sung-Eun
Cho, Byung-Sik
Eom, Ki-Seong
Kim, Yoo-Jin
Kim, Hee-Je
Min, Chang-Ki
Cho, Seok-Goo
Lee, Jong Wook
Lee, Seok
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 135 - 139
[10] Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia
Thomas, Xavier
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (06) : 871 - 878

← 1 2 3 4 5 →